PLK1 and glioblastoma: Since inhibition of DDR and induction of DNA damage often result in synergistic tumor ablation [28], our results suggest that PLK1 inhibition would enhance the tumoricidal effect of TMZ, the DNA damaging chemotherapeutic agent routinely used in glioblastoma treatment.